New award for carbidopa-levodopa SA tablets with mylan pharmaceuticals INC. The period of performance is may 21, 2020 to may 20, 2020 with four one year options.
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79720D0022
- Awardee
-
Mylan Pharmaceuticals Inc. UEI NDN1MYB8DKK5
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- Carbidopa-Levodopa SA Tablets Pre-Solicitation · 36E79720R0006 · Posted Nov 19, 2019
- 6505--Carbidopa-Levodopa SA Tablets Effective 5/21/2020 - 5/20/2021 Award Notice · Posted Mar 12, 2020
- Carbidopa_Levodopa SA Tablets (VA-20-00001507) Solicitation · Posted Dec 9, 2019
- Last date to order 100% complete
- IDV ceiling
- $15,670,215.75
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) held by Mylan Pharmaceuticals Inc. to provide Carbidopa-Levodopa sustained-action (SA) tablets to the Department of Veterans Affairs (VA) National Acquisition Center. The contract has a 5-year period of performance from May 2020 to May 2025, with a ceiling value of $15,670,215.75. Under this IDC, Mylan will annually supply an estimated 50,537 bottles of 100mg Carbidopa-Levodopa SA tablets and 66,850 bottles of 200mg Carbidopa-Levodopa SA tablets to the VA, Bureau of Prisons, and Indian Health Service. These specialty pharmaceutical products are distributed through the VA's Pharmaceutical Prime Vendor program to support the healthcare needs of U.S. veterans. Mylan, as a for-profit manufacturer, has a history of providing a range of critical prescription medications to federal agencies through both IDCs and Federal Supply Schedule contracts. This latest award further solidifies Mylan's position as a key supplier of pharmaceutical products to the VA and other government healthcare customers.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Add Subcontract Plan | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Add Subcontract Plan | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Add Subcontract Plan | $0 | |
| Exercise an Option | $0 | |
| Add Subcontract Plan | $0 | |
| Exercise an Option | $0 | |
| Add Subcontract Plan | $0 | |
| Original award | $0 |
Show all 12
Quick answers
Who was awarded contract 36E79720D0022?
36E79720D0022 was awarded to Mylan Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on May 21, 2020.
How much is contract 36E79720D0022 worth?
36E79720D0022's own ceiling is $15,670,216.
Who can order from contract 36E79720D0022?
36E79720D0022 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 36E79720D0022 competed?
The extent of competition for 36E79720D0022 was full and open competition. The government received 3 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV